NYSE Amex LLC Accepts Plan of Compliance of The Quantum Group, Inc.
03 Juin 2009 - 1:10PM
PR Newswire (US)
WELLINGTON, Fla., June 3 /PRNewswire-FirstCall/ -- The Quantum
Group, Inc. (NYSE Amex: QGP) (the "Company"), announced today that
on May 28, 2009, the NYSE Amex LLC (the "Exchange") accepted the
Company plan of compliance with respect to its previously disclosed
listing deficiency as set forth in Section 1003(a)(iv) of the
Exchange Company Guide. The Company was afforded the opportunity to
submit a plan of compliance to the Exchange and on April 15, 2009
presented its plan to the Exchange, with subsequent submissions to
the plan. On May 28, 2009, the Exchange notified the Company that
it accepted the Company plan of compliance and granted the Company
an extension until September 17, 2009, to regain compliance with
the continued listing standards. The Company will be required to
provide the Exchange staff with updates in conjunction with the
initiatives of the plan of compliance as appropriate or upon the
Exchange's request and the Exchange staff will review the Company
periodically for compliance with the plan of compliance during the
extension period. Failure to make progress consistent with the plan
of compliance or to regain compliance with the continued listing
standards by the end of the extension period could result in the
Company being delisted from the Exchange. About The Quantum Group,
Inc. The Quantum Group is an innovation-driven Healthcare Services
Organization (HSO) that provides business process solutions,
service chain management, strategic consulting and leading edge
technology to the healthcare industry. Quantum has developed and
deployed PWeR(TM) (http://www.mypwer.com/), a cutting-edge,
patent-pending healthcare technology system that has been designed
to bridge the gaps of communication and exchange of patient
information throughout the healthcare industry. To date eighteen
provisional and one utility patent application have been filed in
support of PWeR. The system can integrate all of the functions a
physician/provider, hospital, clinic and related professionals
utilize in one patient-centric, web-based platform and falls well
within the economic incentives offered by the new $19 billion
Stimulus Package for healthcare information technology. We believe
we are positioned to be a catalyst for change as we take aim at the
$700 billion inefficiency gap in the United States healthcare
industry. For more information, please visit
http://www.quantummd.com/. Certain statements contained in this
news release, which are not based on historical facts, are
forward-looking statements as the term is defined in the Private
Securities Litigation Reform Act of 1995, and are subject to
substantial uncertainties and risks in part detailed in the
Company's 10-K, 10-Q, 8-K and other filings with the SEC (and
amendments thereto) that may cause actual results to materially
differ from projections. Forward-looking statements can be
identified by the use of words such as "expects," "plans," "will,"
"may," "anticipates," "believes," "should," "intends," "estimates"
and other words of similar meaning. These statements are subject to
risks and uncertainties that cannot be predicted or quantified and,
consequently, actual results may differ materially from those
expressed or implied by these forward-looking statements. Such risk
factors include, without limitation, the ability of the Company to
properly execute its business model, to raise substantial and
immediate additional capital to implement its business model, to
attract and retain executive, management and operational personnel,
to continue growing its patient base, to negotiate favorable
current debt and future capital raises, to negotiate favorable
agreements with a diversified provider base and to continue to
supply the services needed by its HMO clients as well as physician
clients. The Company does not undertake any obligation to publicly
update any forward-looking statements. As a result, investors
should not place undue reliance on these forward-looking
statements. FOR MORE INFORMATION, PLEASE CONTACT: RedChip Companies
Dave Gentry: 407.644.4256 x104 or PR Financial Marketing Jim
Blackman: 713.256.0369 or The Quantum Group, Inc. Danielle Amodio:
561.798.9800 DATASOURCE: The Quantum Group, Inc. CONTACT: RedChip
Companies, Dave Gentry: +1-407-644-4256 x104, , or PR Financial
Marketing, Jim Blackman, +1-713-256-0369, ; or The Quantum Group,
Inc., Danielle Amodio, +1-561-798-9800, Web Site:
http://www.quantummd.com/
Copyright